Development and Validation of an Immune-Related Prognostic Signature for Laryngeal Squamous Cell Carcinoma.

Changding He, Wanqiu Peng, Yi Shi, Huaidong Du

Abstract read

In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Changding HeDepartment of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Wanqiu PengZhongshan Hospital, Fudan University, Shanghai 200032, China.ORCID 0009-0002-4488-7646

Yi ShiDepartment of Clinical Laboratory, Punan Branch of Renji Hospital, Shanghai Jiao Tong University, Shanghai 201312, China.

Huaidong DuDepartment of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Funding

Zhongshan Hospital ZSLCYJZX202561

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune-related geneslaryngeal squamous cell carcinomaprecision oncologyrisk stratification

Identifiers

PMID42513296

DOI10.3390/jcm15145382

PMCPMC13412633

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.